Competitive Product Launch Resourcing: Activity and Investment Benchmarks

• Industry investments for pharma product launches (pre-launch years to launch year)
• Launch resource allocation based on PYSF
• Launch investment distribution across commercial, medical, and patient access activities
• Pre- and post-COVID launch investment trends

• Total U.S. investment trends for the three pre-launch years and the launch year – by PYSF
• Gauging the product’s total commercial and medical investment by year
• Investment breakdown for years – 3, – 2, – 1, and the launch year – by PYSF
• Annual distribution of benchmark archetypes and function-based spend across pre-launch and launch years
• Comparison of post-COVID and pre-COVID commercial and medical activity investments across pre-launch and launch years
• Proportional activity investment distribution by year
• Breakdown of spend distribution by market archetype for commercial and medical activities in pre-launch and launch years
• Mitigating risks of underserved critical areas and improving launch strategy
• Allocation of investment by activity category for years – 3, – 2, and – 1, and the launch year
• Year-over-year launch activity investment changes
• Investment focus for years – 3, – 2, and – 1: Top-prioritized categories and tactical efforts

• Distribution of Activity Investment By Year: Post-COVID commercial activity investments focus much more on DTC expenses and sales force prep with a muted emphasis on early market research.

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.